Comparison of genomic status between patients with high- and non–high-risk CLL/SLL before applying IPTW
| Genomic status . | High-risk patients (n = 969) . | Non–high-risk patients (n = 273) . | P value . |
|---|---|---|---|
| del(17p), n (%) | <.0001† | ||
| Absent | 577 (59.5) | 273 (100.0) | |
| Present | 319 (32.9) | 0 (0.0) | |
| Unknown | 73 (7.6) | 0 (0.0) | |
| del(11q), n (%) | <.0001† | ||
| Absent | 530 (54.7) | 273 (100.0) | |
| Present | 356 (36.7) | 0 (0.0) | |
| Unknown | 83 (8.6) | 0 (0.0) | |
| IGHV, n (%) | <.0001† | ||
| Unmutated | 569 (58.7) | 0 (0.0) | |
| Mutated | 84 (8.7) | 273 (100.0) | |
| Unknown | 316 (32.6) | 0 (0.0) | |
| del(13q), n (%) | <.0001† | ||
| Absent/unknown | 514 (53.0) | 101 (37.0) | |
| Present | 455 (47.0) | 172 (63.0) | |
| Trisomy 12, n (%) | |||
| Absent/unknown | 741 (76.5) | 207 (75.8) | .824 |
| Present | 228 (23.5) | 66 (24.2) |
| Genomic status . | High-risk patients (n = 969) . | Non–high-risk patients (n = 273) . | P value . |
|---|---|---|---|
| del(17p), n (%) | <.0001† | ||
| Absent | 577 (59.5) | 273 (100.0) | |
| Present | 319 (32.9) | 0 (0.0) | |
| Unknown | 73 (7.6) | 0 (0.0) | |
| del(11q), n (%) | <.0001† | ||
| Absent | 530 (54.7) | 273 (100.0) | |
| Present | 356 (36.7) | 0 (0.0) | |
| Unknown | 83 (8.6) | 0 (0.0) | |
| IGHV, n (%) | <.0001† | ||
| Unmutated | 569 (58.7) | 0 (0.0) | |
| Mutated | 84 (8.7) | 273 (100.0) | |
| Unknown | 316 (32.6) | 0 (0.0) | |
| del(13q), n (%) | <.0001† | ||
| Absent/unknown | 514 (53.0) | 101 (37.0) | |
| Present | 455 (47.0) | 172 (63.0) | |
| Trisomy 12, n (%) | |||
| Absent/unknown | 741 (76.5) | 207 (75.8) | .824 |
| Present | 228 (23.5) | 66 (24.2) |
Indicates P value <.05.